Stephen Andrew Cohen sold $43M of PLTR
See Remarks at Palantir Technologies Inc.. 344,053 shares at an average of $126.35, traded May 20, 2025, filed May 22, 2025.
Score components
- +15RoleOfficer
- +25Trade size$43.5M at market
- +20Share of holdings soldSold 100% of holdings
- +8Cluster2 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001321655-25-000076, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 20, 2025 | CConversion Class A Common Stock | +309,696 | - | - | 310,288 | May 22, 2025 |
| May 20, 2025 | SOpen-market sale Class A Common Stock | -41,744 | $125.46 | $5.2M | 268,544 | May 22, 2025 |
| May 20, 2025 | SOpen-market sale Class A Common Stock | -155,287 | $126.24 | $20M | 113,257 | May 22, 2025 |
| May 20, 2025 | SOpen-market sale Class A Common Stock | -111,834 | $126.94 | $14M | 1,423 | May 22, 2025 |
| May 20, 2025 | SOpen-market sale Class A Common Stock | -831 | $127.71 | $106k | 592 | May 22, 2025 |
| May 21, 2025 | CConversion Class A Common Stock | +34,357 | - | - | 34,949 | May 22, 2025 |
| May 21, 2025 | SOpen-market sale Class A Common Stock | -12,418 | $125.26 | $1.6M | 22,531 | May 22, 2025 |
| May 21, 2025 | SOpen-market sale Class A Common Stock | -15,866 | $126.18 | $2.0M | 6,665 | May 22, 2025 |
| May 21, 2025 | SOpen-market sale Class A Common Stock | -6,073 | $126.85 | $770k | 592 | May 22, 2025 |
| May 20, 2025 | MOption exercise Restricted Stock Unitsderivative | -675,000 | $0.00 | $0 | 2,700,000 | May 22, 2025 |
| May 20, 2025 | MOption exercise Class B Common Stockderivative | +675,000 | $0.00 | $0 | 12,877,734 | May 22, 2025 |
| May 20, 2025 | CConversion Class B Common Stockderivative | -309,696 | $0.00 | $0 | 12,568,038 | May 22, 2025 |
| May 21, 2025 | CConversion Class B Common Stockderivative | -34,357 | $0.00 | $0 | 12,533,681 | May 22, 2025 |
Related signals
Other insiders at Palantir Technologies Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 8Weak | Palantir Technologies Inc. | Lauren Elaina Friedman Stat director | $254k 1,337 shares | -3% | |
| 28Weak | Palantir Technologies Inc. | Alexander D. Moore director | $2.8M 16,000 shares | -1% | |
| 16Weak | Palantir Technologies Inc. | Lauren Elaina Friedman Stat director | $245k 1,342 shares | -2% | |
| 36Weak | Palantir Technologies Inc. | Jeffrey Buckley See Remarks | $240k 1,897 shares | -5% | |
| 25Weak | Palantir Technologies Inc. | Stephen Andrew Cohen See Remarks | $27M 310,000 shares | -100% | |
| 25Weak | Palantir Technologies Inc. | Stephen Andrew Cohen See Remarks | $310M 3,750,000 shares | -300% | |
| 33Weak | Palantir Technologies Inc. | Stephen Andrew Cohen See Remarks | $69M 675,000 shares | -218% | |
| 13Weak | Palantir Technologies Inc. | Alexander C. Karp See Remarks | $45M 432,565 shares | -6% | |
| 10Weak | Palantir Technologies Inc. | David A. Glazer See Remarks | $7.0M 96,273 shares | -25% | |
| 40Moderate | Palantir Technologies Inc. | David A. Glazer See Remarks | $23M 315,126 shares | -52% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.